Salicylic acid: old and new implications for the treatment of type 2 diabetes? - Wikidata - awgldk - TriplyDB

Salicylic acid: old and new implications for the treatment of type 2 diabetes?

Salicylic acid: old and new implications for the treatment of type 2 diabetes?

http://www.wikidata.org/entity/Q41021948

about

Adipokines and inflammatory markers in elderly subjects with high risk of type 2 diabetes and cardiovascular disease

P2860

Q58707565-97775C70-1B97-483E-A569-C648BDF8F03A

P2860

Salicylic acid: old and new implications for the treatment of type 2 diabetes?

http://www.wikidata.org/entity/Q41021948

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Salicylic acid: old and new implications for the treatment of type 2 diabetes?

@en

type

label

Salicylic acid: old and new implications for the treatment of type 2 diabetes?

@en

prefLabel

Salicylic acid: old and new implications for the treatment of type 2 diabetes?

@en

P1433

Q41021948-73A71133-40F0-4CE4-A099-90EFCA115374

P1476

Q41021948-58196C02-72B4-489C-A06B-5ED12686A839

P2093

Q41021948-B144F192-422B-428D-9780-B0E52DB8EACA

P2860

Q41021948-0DB471FA-96C3-42AF-B0EA-29D091DDEBAB

Q41021948-10B33DCB-EF09-4A9A-974F-BE6E49B9DBFD

Q41021948-1D272072-36CA-4950-BA0F-D669E2A3411F

Q41021948-1E2F8205-DA94-4280-8122-2209F9ABF898

Q41021948-23698B96-B011-419D-9655-C139559BCFAF

Q41021948-2A2700AC-01E2-4609-9B50-150D4E4002B9

Q41021948-2EE3277A-E259-4657-96E0-989BFEE583F5

Q41021948-334EB47F-A654-4761-AC3E-7F401DD233A1

Q41021948-3A1D25DC-6F08-40DB-BAF9-B680B06FB916

Q41021948-3B860F7C-D4E6-42D7-A722-4315E48B118E

P2888

Q41021948-00BA28DC-E330-4B8F-83D3-74A49CC5D85E

P304

Q41021948-7F42EC5D-3ED6-4518-8CB3-8F97BB6C9996

P31

Q41021948-69C2DC91-D6CA-42C4-A15C-3632AB7BB73A

P356

Q41021948-449A5649-E2B4-47EF-8C9E-814C2A621246

P433

Q41021948-69294AE7-5E9F-4F26-A8CF-7110FF3BCC0A

P478

Q41021948-3E2C29C7-2572-430E-96BF-DEDC7932B151

P50

Q41021948-CE6F417F-E726-4F81-B8FE-DAE497F88270

P577

Q41021948-E77567CB-A97B-46C3-B5B3-09EB343D19B0

P5875

Q41021948-59129F3A-33B7-4723-AFDA-4C43F07ADB81

P698

Q41021948-322F056D-A4EE-4D2C-BC8E-618164DA9ED9

P921

Q41021948-F5EA3184-3C74-4F6B-B4D3-A0524F1475E4

P932

Q41021948-F548377D-603C-414C-9856-20AB62DAD30A

P356

S13340-014-0177-8

P1433

Diabetology international

P1476

Salicylic acid: old and new implications for the treatment of type 2 diabetes?

@en

P2093

Kei Sakamoto

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and insulin resistance

Molecular mechanism of action of metformin: old or new insights?

The ancient drug salicylate directly activates AMP-activated protein kinase

AMP-activated protein kinase: a target for drugs both ancient and modern

Structural basis of AMPK regulation by small molecule activators

Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta

Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes

Prevention of fat-induced insulin resistance by salicylate

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

IKK-beta links inflammation to obesity-induced insulin resistance

P2888

s13340-014-0177-8

P304

212-218

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13340-014-0177-8

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276943831

http://www.w3.org/2001/XMLSchema#string

P698

27656338

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

5012410

http://www.w3.org/2001/XMLSchema#string